Low-dose naltrexone (LDN) is being explored as a potential treatment for rheumatoid arthritis (RA) and other inflammatory conditions. Here are some key points about LDN:
1. Off-Label Use: LDN is used off-label for conditions like RA, meaning it's used in a way not approved by the FDA for its original intended purposes.
2 Show Full Answer
Low-dose naltrexone (LDN) is being explored as a potential treatment for rheumatoid arthritis (RA) and other inflammatory conditions. Here are some key points about LDN:
1. Off-Label Use: LDN is used off-label for conditions like RA, meaning it's used in a way not approved by the FDA for its original intended purposes.
2. Mechanism of Action: Naltrexone, the drug used in LDN, works by binding to opioid receptors in the brain, which helps block the effects of opioids and alcohol. This mechanism is also being studied for its potential anti-inflammatory effects in RA.
3. Dosage: Typically, LDN is prescribed at about one-tenth the dose used for treating opioid and alcohol use disorders, commonly around 4.5 milligrams daily.
4. Availability: Since there is no commercial low-dose formulation, LDN must be obtained through a compounding pharmacy.
5. Cost: LDN is relatively inexpensive compared to other RA medications, with costs around $35 per month, including the compounding.
6. Research: The effectiveness of LDN in treating RA is still under investigation, with only a few studies conducted so far.
If you're considering LDN for RA, it's important to discuss it with your healthcare provider to understand the potential benefits and risks.
May 12, 2024
Join
Your Privacy Choices
